Advertisement

Topics

EMA panel recommends Dicerna's primary hyperoxaluria drug for orphan status

05:50 EDT 12 Jul 2018 | SmartBrief

The European Medicines Agency's Committee for Orphan Medicinal Products recommended Dicerna Pharmaceuticals' DCR-PHXC as an o -More

Original Article: EMA panel recommends Dicerna's primary hyperoxaluria drug for orphan status

NEXT ARTICLE

More From BioPortfolio on "EMA panel recommends Dicerna's primary hyperoxaluria drug for orphan status"

Advertisement
Quick Search
Advertisement
Advertisement